Items where authors include "Parker, WAE"

Article

Parker, WAE, Sagar, R, Kurdee, Z et al. (5 more authors) (2021) A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control. Cardiovascular Diabetology, 20. 238. ISSN 1475-2840

Parker, WAE, Schulte, C, Barwari, T et al. (6 more authors) (2020) Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels. Cardiovascular Diabetology, 19. 3. ISSN 1475-2840

Parker, WAE, Orme, RC, Hanson, J et al. (11 more authors) (2019) Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome. Platelets, 30 (2). pp. 148-157. ISSN 0953-7104

Sumaya, W, Parker, WAE, Fretwell, R et al. (12 more authors) (2018) Pharmacodynamic Effects of a 6-Hour Regimen of Enoxaparin in Patients Undergoing Primary Percutaneous Coronary Intervention (PENNY PCI Study). Thrombosis and Haemostasis, 118 (07). pp. 1250-1256. ISSN 0340-6245